摘要
目的分析在患有早发冠心病急性心肌梗死患者的临床药物治疗当中,阿托伐他汀与瑞舒伐他汀的不同疗效。方法选择我院2018年1月至2019年2月收治的68例早发冠心病急性心肌梗死患者作为主要研究对象,将其随机均匀分作对照组与分析组,对照组患者接受阿托伐他汀治疗,分析组患者则需接受瑞舒伐他汀治疗,分析两组患者接受不同药物治疗后的实际效果以及出现的并发症情况。结果分析组患者整体疗效远好于对照组,且出现并发症的例数少于对照组,两组患者的相关数据分析后差异存在统计学意义(P<0.05)。结论治疗早发冠心病急性心肌梗死患者时,应用瑞舒伐他汀的效果相对更好,可在临床中进行应用。
Objective To analyze the different effects of atorvastatin and rosuvastatin in clinical drug therapy for patients with early-onset coronary heart disease acute myocardial infarction.Methods Sixty-eight patients with early-onset coronary heart disease acute myocardial infarction admitted to our hospital from January 2018 to February 2019 were selected as the main subjects.They were randomly divided into control group and analysis group,and control group patients received atorvastatin.Patients in the analysis group were treated with rosuvastatin.The actual effects and complications of the two groups of patients after receiving different medications were observed.Results The overall efficacy of the patients in the analysis group was much better than that in the control group,and the number of complications was lower than that in the control group,there was a statistically significant difference between the two groups(P<0.05).Conclusion For the treatment of patients with early-onset coronary heart disease acute myocardial infarction,the effect of rosuvastatin is relatively better.The drug can be applied in clinic.
作者
穆山丹
MU Shandan(Department of Pharmacy,the 79th Army Hospital of the Chinese People's Liberation Army,Liaoyang 111000,China)
出处
《中国医药指南》
2021年第11期45-46,共2页
Guide of China Medicine
关键词
早发冠心病急性心肌梗死
瑞舒伐他汀
阿托伐他汀
疗效
并发症
Early-onset coronary heart disease acute myocardial infarction
Rosuvastatin
Atorvastatin
Efficacy
Complications
